Ufo Believer Posted October 28, 2009 #1 Share Posted October 28, 2009 From - Natural News Internal documents acquired as part of a series of lawsuits show that pharmaceutical giant AstraZeneca planned as early as 2001 to market its antipsychotic drug Seroquel for uses not approved by the FDA. Under U.S. law, drug makers are prohibited for marketing their drug for any use not approved by the FDA. Doctors are still permitted to prescribe drugs, however, for any use they wish. Seroquel (generic name quetiapine) was approved for the treatment of psychotic disorders in adults in 1997. In 2001, the FDA extended this approval to cover schizophrenia. In 2004, it was approved for use of bipolar mania, and in 2006 it was approved for bipolar disorder. Yet AstraZeneca is now the defendant in thousands of lawsuits claiming, among other allegations, that the company actively marketed the drug for use in children and adolescents, and also sought to market it as a treatment for dementia in the elderly. In some of the retrieved documents, AstraZeneca employees and employees of a consulting firm hired by the company reference plans to "broaden Seroquel use on- and off-label," specifically mentioning adolescents and people suffering from Alzheimer's or Parkinson's disease. Areas where the company could promote this use are listed, including sales calls and meetings with medical professionals or patient advocacy groups. More here: http://www.naturalnews.com/027344_Astrazeneca_Seroquel_drugs.html Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now